Prostate cancer screening between low-income African-American and Caucasian men

Urologic Oncology: Seminars and Original Investigations

Volumn 23, Issue 5, 2005, Pages 333-340

  Fowke, Jay H ^a   Schlundt, David ^b   Signorello, Lisa B ^a,c   Ukoli, Flora A M ^d   Blot, William J ^a,c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^d MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Prostate cancer; Prostate specific antigen; Race; Screening; Socioeconomic status

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGE; AGED; ANAMNESIS; ARTICLE; CANCER SCREENING; CAUCASIAN; DEMOGRAPHY; DIGITAL RECTAL EXAMINATION; EDUCATION; HEALTH CENTER; HEALTH INSURANCE; HUMAN; INTERVIEW; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MARRIAGE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; SOCIAL STATUS; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PALPATION; PHYSICAL EXAMINATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; SOCIOECONOMIC FACTORS;

EID: 24344456654     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2005.01.002     Document Type: Article

References (31)

1. A. Jemal, T. Murray, A. Samuels Cancer Statistics, 2003 CA Cancer J Clin 53 2003 5 26
2. I.J. Powell, F.L. Meyskens Jr African American men and hereditary/familial prostate cancer Intermediate-risk populations for chemoprevention trials Urology 57 2001 178 181
3. V. Narain, R. Tiguert, M. Banerjee Biochemical recurrence after radical prostatectomy in black and white American men with a positive or negative family history of prostate cancer J Urol 165 2001 474 477
4. I.J. Powell, M. Banerjee, M. Novallo Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease Urology 55 2000 246 251
5. R.M. Merrill, J.L. Lyon Explaining the difference in prostate cancer mortality rates between white and black men in the United States Urology 55 2000 730 735
6. N. Makridakis, R.K. Ross, L. Crocitto Association of mis-sense substitution in SRD5a2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA Lancet 354 1999 975 978
7. I.J. Powell, J. Carpten, G. Dunston African-American heredity prostate cancer study A model for genetic research J Natl Med Assoc 93 2001 25S 28S
8. R.B. Hayes, R.G. Ziegler, G. Gridley Dietary factors and risks for prostate cancer among Blacks and Whites in the United States Cancer Epidemiol Biomarkers Prev 8 1999 25 34
9. A.S. Whittemore, L.N. Kolonel, A.H. Wu Prostate cancer in relation to diet, physical activity, and body size in Blacks, Whites, and Asians in the United States and Canada J Natl Cancer Inst 87 1995 652 661
10. W. Demark-Wahnefried, T. Strigo, K. Catoe Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening Urology 46 1995 346 351
11. S.P. Weinrich, M.D. Boyd, M. Weinrich Increasing prostate cancer screening in African American men with peer- educator and client-navigator interventions J Cancer Educ 13 1998 213 219
12. N. Breen, D.K. Wagener, M.L. Brown Progress in cancer screening over a decade Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys J Natl Cancer Inst 93 2001 1704 1713
13. R.M. Hoffman, F.D. Gilliland, J.W. Eley Racial and ethnic differences in advanced-stage prostate cancer the Prostate Cancer Outcomes Study J Natl Cancer Inst 93 2001 388 395
14. R. Etzioni, K.M. Berry, J.M. Legler Prostate-specific antigen testing in black and white men An analysis of Medicare claims from 1991-1998 Urology 59 2002 251 255
15. M.S. Tingen, S.P. Weinrich Demographic predictors of participation in prostate cancer screening Nurse Pract 22 1997 17
16. R. Etzioni, D.F. Penson, J.M. Legler Overdiagnosis due to prostate-specific antigen screening Lessons from U.S Prostate cancer incidence trends. J Natl Cancer Inst 94 2002 981 990
17. L. Liu, W. Cozen, L. Bernstein Changing relationship between socioeconomic status and prostate cancer incidence J Natl Cancer Inst 93 2001 705 709
18. R.G. Roetzheim, N. Pal, C. Tennant Effects of health insurance and race on early detection of cancer J Natl Cancer Inst 91 1999 1409 1415
19. R.M. Merrill Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah Prev Med 33 2001 646 652
20. S.P. Weinrich, M. Weinrich, C. Mettlin Urinary symptoms as a predictor for participation in prostate cancer screening among African American men Prostate 37 1998 215 222
21. Federal Register. Physician fee schedule for calendar year 2000 1999 U.S. Government Washington, DC 59429 59478 October 2
22. T. Jordan, J. Price, K. King The validity of male patients' self-reports regarding prostate cancer screening Prev Med 28 1999 297 303
23. R.J. Volk, A.R. Cass The accuracy of primary care patients' self-reports of prostate-specific antigen testing Am J Prev Med 22 2002 56 58
24. L.E. Ross, R.J. Coates, N. Breen Prostate-specific antigen test use reported in the 2000 National Health Interview Survey Prev Med 38 2004 732 744
25. S.A. Eisen, B. Waterman, C.S. Skinner Sociodemographic and health status characteristics associated with prostate cancer screening in a national cohort of middle-aged male veterans Urology 53 1999 516 522
26. T. Gilligan, P.S. Wang, R. Levin Racial differences in screening for prostate cancer in the elderly Arch Intern Med 164 2004 1858 1864
27. K. McDavid, T. Melnik, H. Derderian Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997 Prev Med 31 2000 195 202
28. G. Lu-Yao, T.A. Stukel, S.L. Yao Prostate-specific antigen screening in elderly men J Natl Cancer Inst 95 2003 1792 1797
29. D. Gyrd-Hansen, J. Sogaard Analysing public preferences for cancer screening programmes Health Econ 10 2001 617 634
30. T.I. Shireman, J. Tsevat, S.J. Goldie Time costs associated with cervical cancer screening Int J Technol Assess Health Care 17 2001 146 152
31. C. Cooper, T.L. Merritt, L.E. Ross To screen or not to screen, when clinical guidelines disagree Primary care physicians' use of the PSA test Prev Med 38 2004 182 191